Author

Gianni Frascotti

University of Milano-BicoccaORCID 0000-0002-5963-7650Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:genome assembly· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1 Organism:yeast· 1

Frequent Co-Authors

Andrea BanfiiD· 1 shared Chiara BaioniiD· 1 shared Chiara DamianiiD· 1 shared Danilo PorroiD· 1 shared Dario PesciniiD· 1 shared Davide ProsperiiD· 1 shared Kenneth H. WolfeiD· 1 shared Linda BarbieriiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Andrea BanfiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual-targeting strategy to repurpose Cetuximab with HFn nanoconjugates for immunotherapy of triple-negative breast cancer

Linda Barbieri, Lucia Salvioni, Andrea Banfi, Stefania Garbujo, Luisa Fiandra, Chiara Baioni, Marco Giustra, Lucia Morelli, Gianni Frascotti, Miriam Colombo, Metello Innocenti, Davide Prosperi

This paper develops a dual-targeting nanoconjugate using Cetuximab and H-ferritin to enhance immunotherapy for TNBC by improving ADCC and tumor targeting.

ACS Applied Materials & Interfaces · May 6, 2025Peer-reviewedBiochemistry

Genome-scale metabolic construction of the stress-tolerant hybrid yeast Zygosaccharomyces parabailii

Marzia Di Filippo, Raúl A. Ortiz‐Merino, Chiara Damiani, Gianni Frascotti, Danilo Porro, Kenneth H. Wolfe, Paola Branduardi, Dario Pescini

The paper reconstructs the first genome-scale metabolic model for Zygosaccharomyces parabailii, demonstrating its potential for metabolic engineering and industrial applications.

bioRxiv · Jul 20, 2018 · PreprintSystems Biology